Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
about
Interpatient variability in dexmedetomidine response: a survey of the literatureDexmedetomidine: A Review of Its Use for Sedation in the Intensive Care SettingThe effects of different loading doses of dexmedetomidine on sedation.Effects of dexmedetomidine on smooth emergence from anaesthesia in elderly patients undergoing orthopaedic surgery.Optimal dose of dexmedetomidine for sedation during spinal anesthesiaTHE EFFECT OF OBESITY ON DOSE OF DEXMEDETOMIDINE WHEN ADMINISTERED WITH FENTANYL DURING POSTOPERATIVE MECHANICAL VENTILATION--RETROSPECTIVE.Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery.Risks and benefits of pre-operative dexmedetomidine in oral and maxillofacial surgeries: a systematic review.Pharmacokinetics and pharmacodynamics of dexmedetomidine.Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.Effective dose of dexmedetomidine to induce adequate sedation in elderly patients under spinal anesthesiaUsefulness of Dexmedetomidine during Intracerebral Aneurysm Coiling.Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia.Effective Loading Dose of Dexmedetomidine to Induce Adequate Sedation in Parturients Undergoing Caesarean Section Under Spinal Anaesthesia.Evaluation of pharmacokinetic models of intravenous dexmedetomidine in sedated patients under spinal anesthesia.Dexmedetomidine versus morphine infusion following laparoscopic bariatric surgery: effect on supplemental narcotic requirement during the first 24 h.Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients.All hands on dex.
P2860
Q26994769-31170DA2-11D3-410B-9919-3777EE88AA6FQ28263230-0F32962F-72DD-4108-AF97-9BBD214C282CQ34000964-496125DE-A380-4843-AA1A-9D15345B55C7Q36134984-DE2B4669-153A-4906-B510-E5AA4B27CCB8Q36888481-E94DD448-B880-444D-B13D-887477584B2BQ37461010-514390EF-4AA8-4C78-9B93-50998FBE5552Q38614818-E3272B23-04B7-4225-AE80-C959C431E7BBQ38817602-2656CD7C-262C-48EB-A29F-9F6E2EDC6ECFQ38946488-A891DFAA-EC01-4CCF-9EBB-7F9D9B0155F9Q39096085-2107B9C6-317B-4E58-B4BA-97A923D655E3Q41969369-0C196BAB-1791-4CFC-8D6D-9757F713F0ACQ41991162-CBDBF0C7-8D85-4276-B60F-19407D9E7807Q47220207-310FAE34-4D36-49C9-AEFB-31E3A43292CCQ47233675-74065C53-B193-4F6E-9F0F-C95EAAC7A2BAQ47235643-1915420F-FA26-4905-80E3-8F2BE778CA1CQ47630923-79A50752-B434-45B5-927E-72A2DCF2B446Q47666296-C4BEEE7C-7EEC-492F-A618-0EAE5974CA5BQ48133170-6358C3F6-4499-4302-9DAC-1E21019E0C18
P2860
Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Pharmacokinetics and pharmacod ...... ne in healthy Korean subjects.
@en
Pharmacokinetics and pharmacod ...... ne in healthy Korean subjects.
@nl
type
label
Pharmacokinetics and pharmacod ...... ne in healthy Korean subjects.
@en
Pharmacokinetics and pharmacod ...... ne in healthy Korean subjects.
@nl
prefLabel
Pharmacokinetics and pharmacod ...... ne in healthy Korean subjects.
@en
Pharmacokinetics and pharmacod ...... ne in healthy Korean subjects.
@nl
P2093
P2860
P1476
Pharmacokinetics and pharmacod ...... ne in healthy Korean subjects.
@en
P2093
W Wisemandle
P2860
P304
P356
10.1111/J.1365-2710.2012.01357.X
P577
2012-05-31T00:00:00Z